10X Profit Potential for This Cancer-Fighting Company
While this company’s shares haven’t performed well for us, a positive result could cause a historic boom. The AML market is a large one, and right now this company is valued at just $150 million. At its current valuation, its $11 share price could go north of $100 per share early next year just on Phase 3 data alone.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication(s) below and get access today!
Ray Blanco’s FDA Profit Alert
The FDA Profit Alert focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.
